| Particulars |
|
|
|
| Company Name
| Bliss GVS Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
10.61 |
B.V. (₹) |
108.90 |
| Sales(₹ Cr.) |
729.81 |
NP (₹ Cr.) |
98.34 |
| NP Var% |
42.00 |
Div% |
150.00 |
| CPS(₹) |
12.20 |
EPS (₹) |
9.30 |
| Traded Value(₹ Lakhs) |
271.24 |
52 Week High |
495.00 |
| 52 Week Low |
118.00 |
Price BSE |
493.00 |
| Price NSE |
492.00 |
Market Capital (₹ Cr.) |
5,223.27 |
| P/C Ratio |
40.40 |
P/E Ratio |
53.20 |
| Price Vs.BV |
4.53 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
211.54 |
| NP(₹ Cr.) |
32.16 |
NP Var % |
181.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
656.76 |
| OPM |
10.20 |
NP |
80.82 |
| NP Var% |
42.30 |
EPS |
9.27 |
| PE |
53.13 |
|
|